Log in
Enquire now
Medopad

Medopad

Medopad is an artificial Intelligence company founded in 2011 by Dan Vahdat.

OverviewStructured DataIssuesContributors

Contents

medopad.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Machine learning
Machine learning
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Pharmaceutical industry
Pharmaceutical industry
Healthcare
Healthcare
Technology
Technology
Digital health
Digital health
Location
London
London
Founder
Dan Vahdat
Dan Vahdat
AngelList URL
angel.co/medopad-1
Accelerator
Healthbox
Healthbox
Plug and Play
Plug and Play
Accelerator Batch
‌
Healthbox - Europe Sep 2012
Plug and Play Health Batch 6
Plug and Play Health Batch 6
Investors
Healthbox
Healthbox
NWS Holdings
NWS Holdings
Bayer
Bayer
Founded Date
2011
Total Funding Amount (USD)
51,000,000
Latest Funding Round Date
November 2019
Competitors
Elephant Healthcare
Elephant Healthcare
Latest Funding Type
Series B
Series B
Wellfound ID
medopad-1
Country
United Kingdom
United Kingdom
Headquarters
London
London

Other attributes

Company Operating Status
Active
Wikidata ID
Q18160840
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Medopad - Apps on Google Play

Huma Therapeutics Ltd

https://play.google.com/store/apps/details?id=com.medopad.monitoring&hl=en_

Web

References

Find more companies like Medopad

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.